Fulvestrant
NDC 71731-6121, fulvestrant, injection, from Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
- Product NDC
- 71731-6121
- Status
- Listed
- Labeler
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71731-6121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71731-6121-1 | 71731612101 | 2 SYRINGE, GLASS in 1 CARTON (71731-6121-1) / 5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/46086fe7-190d-4963-97bc-1fe22d36e6d2
Use it
Look up 71731-6121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71731-6121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71731-6121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.